New insights into the mechanism of action of copolymer 1 in experimental allergic encephalomyelitis and multiple sclerosis

Journal of Neurology

Volumn 243, Issue SUPPL. 1, 1996, Pages

  Arnon, Ruth ^a   Sela, Michael ^a   Teitelbaum, Dvora ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Copolymer 1; Experimental allergic encephalomyelitis; Multiple sclerosis

Indexed keywords

GLATIRAMER; IMMUNOSUPPRESSIVE AGENT; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MYELIN ASSOCIATED GLYCOPROTEIN; MYELIN BASIC PROTEIN; PROTEOLIPID PROTEIN;

ALLERGIC ENCEPHALOMYELITIS; ANTIGEN PRESENTING CELL; BRAIN HOMOGENATE; CONFERENCE PAPER; DRUG BINDING; DRUG MECHANISM; EFFECTOR CELL; HUMAN; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; SUPPRESSOR CELL;

ANIMALS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MULTIPLE SCLEROSIS; PEPTIDES; TIME FACTORS;

EID: 0029936443     PISSN: 03405354     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf00873696     Document Type: Article

References (28)

1. Aharoni R, Teitelbaum D, Arnon R (1993) T suppressor hybridomas and interleukin-2-dependent lines induced by copolymer 1 or by spinal cord homogenate down-regulate experimental allergic encephalomyelitis. Eur J Immunol 23:17-25
2. Al-Sabbagh A, Miller A, Santos LMB, et al (1994) Antigen-driven tissue-specific suppression following oral tolerance: orally administered myelin basic protein suppresses proteolipid protein-induced experimental autoimmune encephalomyelitis in the SJL mouse. Eur J Immunol 24:2104-2109
3. Arnon R (1981) Experimental allergic encephalomyelitis - susceptibility and suppression. Immunol Rev 55:5-30
4. Arnon R, Teitelbaum D (1994) Immunospecific drug design prospects for treatment of autoimmune diseases. Ther Immunol 1:65-70
5. Bernard CCA, Kerlero de Rosbo N (1992) Multiple sclerosis: an autoimmune disease of multifunctional etiology. Curr Opin Immunol 4:760-765
6. Bernard CCA, Mandel TE, Mackay IR (1992) Experimental models of human autoimmune disease: overview and prototypes. In: Rose NR, Mackay IR (eds) The autoimmune diseases II. Academic Press, San Diego, pp 47-106
7. Fridkis-Hareli M, Teitelbaum D, Gurevich E, et al (1994) Direct binding of myelin basic protein and synthetic copolymer 1 to class II major histocompatibility complex molecules on living antigen presenting cells - specificity and promiscuity. Proc Natl Acad Sci U S A 91:4872-4876
8. Fridkis-Hareli M, Teitelbaum D, Kerlero de Rosbo N, et al (1994) Synthetic copolymer 1 inhibits the binding of MBP, PLP and MOG peptides to class II major histocompatibility complex molecules on antigen-presenting cells. J Neurochem 63(suppl I):abstract D
9. Fridkis-Hareli M, Teitelbaum D, Arnon R, et al (1995) Synthetic copolymer 1 and myelin basic protein do not require processing prior to binding to class II major histocompatibility complex molecules on living antigen presenting cells. Cell Immunol 163:229-236
10. Greer JM, Kuchroo VK, Sobel RA, et al (1992) Identification and characterization of a second encephalitogenic determinant of myelin proteolipid protein. J Immunol 149:783-788
11. Guery J-C, Adorini L (1993) Selective immunosuppression of class II-restricted T cells by MHC class II-binding peptides. Crit Rev Immunol 13:195-206
12. Keith AB, Arnon R, Teitelbaum D, et al (1979) The effect of Cop 1, a synthetic polypeptide, on chronic relapsing experimental allergic encephalomyelitis in guinea pigs. J Neurol Sci 42: 267-274
13. Kerlero de Rosbo N, Mendel I, Ben-Nun A (1995) Chronic relapsing experimental autoimmune encephalomyelitis with a delayed onset and an atypical clinical course, induced in PL/J mice by myelin oligodendrocyte glycoprotein (MOG)-derived peptide: preliminary analysis of MOG T cell epitopes. Eur J Immunol 25:985-993
14. Lando Z, Teitelbaum D, Arnon R (1979) Effect of cyclophosphamide on suppressor cell activity in ice unresponsive to EAE. J Immunol 132: 2156-2160
15. Lando Z, Teitelbaum D, Arnon R (1981) The immunological response in mice unresponsive to experimental allergic encephalomyelitis. J Immunol 126:1526-1528
16. Sela M, Arnon R, Teitelbaum D (1990) Suppressive activity of Cop 1 in EAE and its relevance to multiple sclerosis. Bull Inst Pasteur 88:303-314
17. Teitelbaum D, Meshorer A, Hirshfeld T, et al (1971) Suppression of experimental allergic encephalomyelitis by a synthetic polypeptide. Eur J Immunol 1:242-248
18. Teitelbaum D, Webb C, Meshorer A, et al (1973) Suppression by several synthetic polypeptides of experimental allergic encephalomyelitis induced in guinea pigs and rabbits with bovine and human basic encephalitogen. Eur J Immunol 3:273-279
19. Teitelbaum D, Meshorer A, Arnon R (1974) Suppression of experimental allergic encephalomyelitis in baboons by Cop 1. Israel J Med Sci 13:1038
20. Teitelbaum D, Webb C, Bree M, et al (1974) Suppression of experimental allergic encephalomyelitis in rhesus monkeys by a synthetic basic copolymer. Clin Immunol Immunopathol 3:256-262
21. Teitelbaum D, Aharoni R, Arnon R, et al (1988) Specific inhibition of the T-cell response to myelin basic protein by the synthetic copolymer Cop 1. Proc Natl Acad Sci U S A 85:9724-9728
22. Teitelbaum D, Aharoni R, Sela M, et al (1991) Cross-reactions and specificities of monoclonal antibodies against myelin basic protein and against the synthetic copolymer 1. Proc Natl Acad Sci USA 88:9528-9532
23. Teitelbaum D, Milo R, Arnon R, et al (1992) Synthetic copolymer 1 inhibits human T cell lines specific for myelin basic protein. Proc Natl Acad Sci USA 89:137-141
24. Tuohy VK, Lu Z, Sobel RA, et al (1989) Identification of an encephalitogenic determinant of myelin proteolipid protein for SJL mice. J Immunol 142:1523-1527
25. Webb C, Teitelbaum D, Arnon R, et al (1973) In-vivo and in-vitro immunological cross-reactions between basic encephalitogen and synthetic basic polypeptides capable of suppressing experimental allergic encephalomyelitis. Eur J Immunol 3:279-286
26. Webb C, Teitelbaum D, Herz A, et al (1976) Molecular requirements involved in suppression of EAE by synthetic basic copolymers of amino acids. Immunochemistry 13:333-337
27. Wisniewski HM, Keith AB (1992) Chronic relapsing experimental allergic encephalomyelitis: an experimental model of multiple sclerosis. Ann Neurol 1:144-148
28. Zamvil SS, Steinman L (1990) The T-lymphocyte in experimental allergic encephalomyelitis. Ann Rev Immunol 8:579-621